NorthStar Medical Technologies of Beloit, Wis., will receive $37 million under two cooperative agreements with the National Nuclear Security Administration for the production of molybdenum-99 without the use of high-enriched uranium. Considered a critical medical radioisotope, Mo-99 is used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.

The Nuclear Regulatory Commission is set to allow about 2 million gallons of low-level radioactive wastewater from the Vermont Yankee nuclear power plant, currently undergoing decommissioning, to be disposed of at an Idaho waste facility. As published in the May 7 Federal Register, the NRC has issued an environmental assessment and finding of no significant impact for a request by NorthStar Nuclear Decommissioning to dispose of the wastewater at US Ecology Idaho’s waste facility near Grand View.

Completing a 5,700-mile journey from Belgium, two 24-ton particle accelerators were delivered to NorthStar Medical Radioisotopes’ facility in Beloit, Wis., on April 22, the Wisconsin State Journal reported. Photos and a video of the accelerators being received at the facility are included in the report.